Catalog # | Description | Price | Qty | Autoship | CART | FAVORITES |
sc-516182Rx | 57 mg, 60 ct | $103.19 | ||||
sc-516183Rx | 57 mg, 180 ct | $293.79 |
Click product's Autoship icon - choose frequency at Checkout.
Never forget a shipment so you're always stocked.
Saves you 5% on UltraCruz® products.
You manage the frequency or cancellation to fit your needs.
EQUIOXX® is the first non-steroidal anti-inflammatory drug (NSAID) of the coxib class used to control pain and inflammation associated with osteoarthritis in horses that has been approved for use in the U.S. EQUIOXX® Tablets are chewable and easy to administer to horses, with or without feed.
Both the USEF and AQHA (and many of the groups that use these organizations for their guidelines) have approved the use of EQUIOXX at the recommended dose 12 hours prior to competition. Furthermore, EQUIOXX is the only NSAID approved for use up to 14 successive days by these two groups.